US 11866515
Hemiasterlin derivatives for conjugation and therapy
granted A61KA61K38/00A61K47/6817
Quick answer
US patent 11866515 (Hemiasterlin derivatives for conjugation and therapy) held by Sutro Biopharma, Inc. expires Mon Jan 04 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Sutro Biopharma, Inc.
- Grant date
- Tue Jan 09 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jan 04 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 12
- CPC classes
- A61K, A61K38/00, A61K47/6817, A61K47/6855, A61P